Signal active
Organization
Contact Information
Overview
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets.
It was founded in 2014 and is headquartered in Ann Arbor, Michigan.
About
Developer Tools, Enterprise Software, Software, Medical, Genetics
2014
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Genomenon headquartered in United States, North America, operates in the Developer Tools, Enterprise Software, Software, Medical, Genetics sector. The company focuses on Developer Tools and has secured $6.9B in funding across 180 round(s). With a team of 11-50 employees, Genomenon is actively contributing to advancements in Developer Tools. Their latest funding round, Seed Round - Genomenon, raised $446.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
9
0
0
$38.2M
Details
6
Genomenon has raised a total of $38.2M in funding over 6 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Early Stage Venture | 20.0M | ||
2016 | Seed | 410.0K | ||
2016 | Seed | 940.0K | ||
2015 | Seed | 446.0K |
Investors
Genomenon is funded by 43 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Invest Detroit | - | FUNDING ROUND - Invest Detroit | 940.0K |
InvestMichigan | - | FUNDING ROUND - InvestMichigan | 940.0K |
Genomenon | - | FUNDING ROUND - Genomenon | 940.0K |
Three Leaf Ventures | - | FUNDING ROUND - Three Leaf Ventures | 940.0K |
Recent Activity
There is no recent news or activity for this profile.